Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 4, 2022
Patent Application Number
16986622
Date Filed
August 6, 2020
Patent Citations
Patent Primary Examiner
The present technology relates to a method of treating one or more behavioral symptoms of Fragile X Syndrome in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of Fragile X Syndrome are treated in the subject.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
